| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/31/2007 | CN1903204A Methionine vitamin B1 for injection and its prepn. method |
| 01/31/2007 | CN1903203A Application of derivative of polysubstituted acyl thiourea pyrimidine for preparing antiviral medicine |
| 01/31/2007 | CN1903200A Medicine for treating gap and vomiting due to nuclear-radiation, radiotherapy and anti-motion sickness |
| 01/31/2007 | CN1903199A Kurarinol dripping pills for treating hepatitis B |
| 01/31/2007 | CN1903198A Kurarinol slow-release dripping pills for treating hepatitis B |
| 01/31/2007 | CN1903197A Nizatidine dispersion tablets |
| 01/31/2007 | CN1903191A Application of artesunate for preparing medicine to treat fibrosis of liver |
| 01/31/2007 | CN1903185A Dispersion tablets and its prepn. method |
| 01/31/2007 | CN1903184A Effervesce tablets for treating liver diseases |
| 01/31/2007 | CN1903183A Dispersion tablets of telbivudine and its prepn. method |
| 01/31/2007 | CN1297653C Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297311C Traditional Chinese medicine preparation for treating incoordination between the spleen and the stomach, its preparation method and application |
| 01/31/2007 | CN1297310C Medicated liquor for curing chronic gastritis and gastric ulcer |
| 01/31/2007 | CN1297304C Aquilarid distillate suspensoid agent and its preparation method |
| 01/31/2007 | CN1297295C Constipation treating Chinese medicinal composition |
| 01/31/2007 | CN1297276C 5-amino-salicylic acid intercalation medicinal slow-release agent and production thereof |
| 01/31/2007 | CN1297272C New use of chlophenamine maleate |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169808 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity |
| 01/30/2007 | US7169799 Process for producing crystal |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169793 An amorphous form of esomeprazole, and dosage forms thereof; enantioselective process involves forming a transition metal complex; treating gastric disorders such as ulcers |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169766 Administering nucleoside, or prodrug thereof; viricides |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169607 In vivo induction for enhanced function of isolated hepatocytes |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | CA2302411C Improved method for preventing crystal formation in a scopolamine transdermal device |
| 01/30/2007 | CA2265615C Reflux inhibitors |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/30/2007 | CA2138991C Treatment for sensitive teeth |
| 01/25/2007 | WO2007010977A1 Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 01/25/2007 | WO2007010692A1 Pharmaceutical composition for treatment of inflammatory bowel disease which targets at hvem and btla, and therapeutic method |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009800A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2007009392A1 The use of chlorogenic acid in the manufacturing medicaments for treating and/or preventing hepatic injury |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006093774B1 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 01/25/2007 | WO2006085143A3 Improved bioactive agent compositions for repair of cell injuries |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021487 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021467 Salts of omeprazole and esomeprazole II |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021460 5-HT7 antagonists; irritable bowel syndrome; diarrhea, constipation |
| 01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020348 Composition for treating hepatitis c |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | CA2616054A1 Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 01/25/2007 | CA2615552A1 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745793A1 Adsorbent for oral administration, therapeutic or preventive agent for kidney disease, and therapeutic or preventive agent for liver disease |
| 01/24/2007 | EP1745792A1 Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease |
| 01/24/2007 | EP1745790A2 Treatment of rumen acidosis with alpha-amylase inhibitors |
| 01/24/2007 | EP1744777A2 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/24/2007 | EP0959872B1 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | CN2860485Y Novel oral cavity medicine |
| 01/24/2007 | CN1902178A Therapeutic agents useful for treating pain |
| 01/24/2007 | CN1901941A Conjugates of angiotensin ii and an imaging moiety |
| 01/24/2007 | CN1901934A Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| 01/24/2007 | CN1901932A Cytokine antagonist molecules |
| 01/24/2007 | CN1901905A Intranasal compositions |
| 01/24/2007 | CN1900100A Rehmannia root oligose and its extracting method |
| 01/24/2007 | CN1900078A Entecavir potassium salt compound and its preparing method and medicine use |
| 01/24/2007 | CN1899613A Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method |
| 01/24/2007 | CN1899612A Therapeutical peptide hepatitis C vaccine and its preparing method |